(Q40056522)

English

Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.

scientific article published on 14 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

prostate cancer screening

1 reference

based on heuristic

inferred from title

Leonardo Oliveira Reis

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Wesley J Magnabosco

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Eliney Ferreira Faria

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Gustavo F Carvalhal

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Rodolfo Borges dos Reis

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Marcos Tobias-Machado

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Renê A C Vieira

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Roberto Dias Machado

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Celso H Freitas

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Edmundo C Mauad

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

André Lopes Carvalho

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

14 August 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

BJU International

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

110

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

E653-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

11 Pt B

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Program for prostate cancer screening using a mobile unit: results from Brazil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11398.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2012.11398.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22892057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40056522&oldid=1513141980"